1. Home
  2. NPKI vs TYRA Comparison

NPKI vs TYRA Comparison

Compare NPKI & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NPK International Inc. Common Stock

NPKI

NPK International Inc. Common Stock

HOLD

Current Price

$12.92

Market Cap

973.4M

Sector

Industrials

ML Signal

HOLD

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$22.03

Market Cap

844.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPKI
TYRA
Founded
1932
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
973.4M
844.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NPKI
TYRA
Price
$12.92
$22.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$14.17
$31.20
AVG Volume (30 Days)
766.9K
462.3K
Earning Date
10-30-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.38
N/A
Revenue
$259,372,000.00
N/A
Revenue This Year
$21.14
N/A
Revenue Next Year
$9.42
N/A
P/E Ratio
$34.16
N/A
Revenue Growth
25.65
N/A
52 Week Low
$4.76
$6.42
52 Week High
$14.00
$22.83

Technical Indicators

Market Signals
Indicator
NPKI
TYRA
Relative Strength Index (RSI) 61.20 72.42
Support Level $11.17 $20.08
Resistance Level $12.62 $22.83
Average True Range (ATR) 0.46 1.60
MACD 0.07 0.20
Stochastic Oscillator 98.45 89.04

Price Performance

Historical Comparison
NPKI
TYRA

About NPKI NPK International Inc. Common Stock

NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: